P3 Health Partners (PIII) - Kapitalizatsiyaning foydaga nisbati

P3 Health - PIII emitenti grafik logotipi

P3 Health Partners Inc. (PIII) qiymatga asoslangan sog'liqni saqlashni rivojlantirish uchun IT mutaxassislar va tibbiyot xodimlarini birlashtirib, bonuslar tizimi va kasbiy charchoqning oldini olish choralaridan foydalanadi. Biroq, davlat dasturlari xarajatlarining keskin ortishi marjalarni qisqartirib, likvidlik inqirozini keltirib chiqardi. GURU.Markets platformasidagi ushbu tarixiy narxlar grafigi -0.10 miqdoridagi P/E koeffitsiyentini ko'rsatmoqda. Biznes samarali boshqaruv va minimal formalizmga tayanadi, bu esa shifokorlarga bemorlarning sog'ayishiga e'tibor qaratish imkonini beradi.

P3 Health Partners, Inc. - PIII Narx-foyda koeffitsiyenti (davr: 04.07.2022 - 12.11.2026)

P3 Health Partners, Inc. (PIII) kompaniyasining tahliliy kesimlari

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Kompaniyaning dastlabki tahlili:PIII, p3hp.org
P3 Health Partners Inc. tomonidan chiqariladigan mahsulotlar

P3 Health Partners Inc. (PIII) shirqatini go'yoki keksayganlar uchun qiymatga asoslangan sog'liqni saqlash sektorida gospitalizatsiya darajalarini kamaytirish orqali xarajatlarni optimallashtirib, daromad keltiradi. Kompaniyaning fundamental P/E koeffitsiyentini tahlil qilish orqali investor bozor kapitalizatsiyasi va sof foyda o'rtasidagi bog'liqlikni o'rganishi mumkin, bu esa likvidlik toraygan sharoitda daromadning har bir dollari qiymatini baholash imkonini beradi va aktivning haqiqiy moliyaviy natijalariga nisbatan haddan tashqari qimmat baholanganligini aniqlaydi.

Raqobatchilar tahlili

Narx-foyda koeffitsiyenti HCA Holdings (HCA)|P/E multiplikatori THC|FMS - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Solventum Inc. SOLV|EHC: Narx-foyda multiplikatori|UHS: Narx-foyda koeffitsiyenti|davita.com - Bozor narxining sof foydaga nisbati|RadNet (RDNT) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati OPCH (Option Care)|Narx-foyda koeffitsiyenti SGRY|Narx-foyda koeffitsiyenti Premier Health (PINC)|National Vision Holdings (EYE) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori progyny.com (PGNY)|Kompaniya qiymatining sof foydaga nisbati Ardent Health Partners|P/E multiplikatori Select Medical Corporation SEM|ASTH (Apollo Medical Holdings) - Kapitalizatsiyaning foydaga nisbati|MD - P/E multiplikatori|USPH: P/E multiplikatori|PNTG (pennantgroup.com) - Narxning foydaga nisbati|Narxning foydaga nisbati Organogenesis|Narx-foyda koeffitsiyenti Nutex Health Inc (NUTX)|Bozor narxining sof foydaga nisbati Auna Health|P/E multiplikatori SBC Medical Group Inc (SBC)|Kompaniya qiymatining sof foydaga nisbati Evolus, Inc.|CYH - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati Beauty Health (SKIN)|MDWD: Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati Biote Corp (BTMD)|The Joint (JYNT) - P/E multiplikatori|DCGO (DocGo Inc.) - P/E multiplikatori|Narxning foydaga nisbati GANX|EUDA Health Holdings Limited (EUDA) - Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti baselmedical.com BMGL|Bozor narxining sof foydaga nisbati CollPlant Biotechnologies Ltd. (CLGN)|Cuprina Holdings Limited - Narxning foydaga nisbati|Concord Medical Services (CCM) - Narx-foyda multiplikatori|AMS - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati MRM|ALBT (Avalon GloboCare Corp.) - Narxning foydaga nisbati|DHAI - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati XAGE|NIVF (NewGenIvf Group Limited) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti atipt.com ATIP|Kompaniya qiymatining sof foydaga nisbati CareMax|P/E multiplikatori Kindly MD Inc KDLY|Biznesning o‘zini qoplash muddati MODV (LogistiCare)|NVOS: Narxning foydaga nisbati|Narx-foyda multiplikatori sunlinkhealth.com|imacholdings.comm (BACK) - P/E multiplikatori